titlesubtitle

freemultihandpoker| The concept of non-alcoholic steatohepatitis (NASH) rose in intraday trading, with Furui shares rising 2.67%

editor|
49

May 27freemultihandpoker, the concept of non-alcoholic steatohepatitis (NASH) rose intraday. As of 10:06, the overall index of non-alcoholic steatohepatitis (NASH) rose 0freemultihandpoker.53%, quoted at 1050freemultihandpoker.040 points.

In terms of individual stocks, among the components of this concept, Furui shares rose 2.67%, with Microchip Biotech, Huadong Pharmaceutical and Nuotai Biotech leading the gainers.

In terms of funds, as of press time, the main net inflow of the non-alcoholic steatohepatitis (NASH) concept was-22.9633 million, of which Furui shares were popular with funds, with a main net inflow of 7.0563 millionfreemultihandpoker; Looking at the extended timeline, the net inflow of main funds in the sector in the past 20 days was-481 million yuan.

freemultihandpoker| The concept of non-alcoholic steatohepatitis (NASH) rose in intraday trading, with Furui shares rising 2.67%

(The above content is Tencent's self-selected shares based on public information and intelligently generated by programs or algorithms. It is only used as a reference for users to watch the market, and is not used as investment advice or trading basis. The stock market is risky, please make decisions carefully.)